Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Increased CD4(+) T Cell Levels during IL-7 Administration of Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Positive Macaques Are Not Dependent on Strong Proliferative Responses
  2. Leone, A.; Rohankhedkar, M.; Okoye, A.; Legasse, A.; Axthelm, M. K.; Villinger, F.; Piatak, M.; Lifson, J. D.; Assouline, B.; Morre, M.; Picker, L. J.; Sodora, D. L.
  3. Journal of Immunology. 2010, Aug; 185(3): 1650-1659.
  1. 2.   CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
  2. Read, S. W.; Lempicki, R. A.; Di Mascio, M.; Srinivasula, S.; Burke, R.; Sachau, W.; Bosche, M.; Adelsberger, J. W.; Sereti, I.; Davey, R. T.; Tavel, J. A.; Huang, C. Y.; Issaq, H. J.; Fox, S. D.; Lane, H. C.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2008 198(6): 843-850.
  1. 3.   Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy
  2. Read, S. W.; Higgins, J.; Metcalf, J. A.; Stevens, R. A.; Rupert, A.; Nason, M. C.; Lane, H. C.; Sereti, I.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2006, Aug; 42(5): 537-544.
  1. 4.   A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus
  2. Tavel, J. A.; Sereti, I.; Walker, R. E.; Hahn, B.; Kovacs, J. A.; Jagannatha, S.; Davey, R. T.; Falloon, J.; Polis, M. A.; Masur, H.; Metcalf, J. A.; Stevens, R.; Rupert, A.; Baseler, M.; Lane, H. C.
  3. Journal of Infectious Diseases. 2003 188(4): 531-536.
  1. 5.   Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells
  2. Sereti, I.; Martinez-Wilson, H.; Metcalf, J. A.; Baseler, M. W.; Hallahan, C. W.; Hahn, B.; Hengel, R. L.; Davey, R. T.; Kovacs, J. A.; Lane, H. C.
  3. Blood. 2002 100(6): 2159-2167.
  1. 6.   CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients
  2. Sereti, I.; Herpin, B.; Metcalf, J. A.; Stevens, R.; Baseler, M. W.; Hallahan, C. W.; Kovacs, J. A.; Davey, R. T.; Lane, H. C.
  3. Aids. 2001 15(14): 1765-1775.
  1. 7.   Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression
  2. Kovacs, J. A.; Imamichi, H.; Vogel, S.; Metcalf, J. A.; Dewar, R. L.; Baseler, M.; Stevens, R.; Adelsberger, J.; Lambert, L.; Davey, R. T.; Walker, R. E.; Falloon, J.; Polis, M. A.; Masur, H.; Lane, H. C.
  3. Journal of Infectious Diseases. 2000 182(4): 1063-1069.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel